Shares of InterMune (ITMN +10.4%) go on an INHX-inspired tear. The firm offers a protease...

|By:, SA News Editor

Shares of InterMune (ITMN +10.4%) go on an INHX-inspired tear. The firm offers a protease inhibitor used by Roche's Hepatitis C treatment candidate.